Serum CA 19-9 as a Biomarker for Pancreatic Cancer-A Comprehensive Review. - Wikidata - awgldk - TriplyDB

Serum CA 19-9 as a Biomarker for Pancreatic Cancer-A Comprehensive Review.

Serum CA 19-9 as a Biomarker for Pancreatic Cancer-A Comprehensive Review.

http://www.wikidata.org/entity/Q38018315

about

A soluble form of the giant cadherin Fat1 is released from pancreatic cancer cells by ADAM10 mediated ectodomain shedding Circulating tumor DNA: a promising biomarker in the liquid biopsy of cancer Detection of circulating tumor DNA in early- and late-stage human malignancies Molecular Imaging of Pancreatic Cancer with Antibodies.Detection of pancreatic cancer with normal carbohydrate antigen 19-9 using protein chip technology.A Novel Multivariate Index for Pancreatic Cancer Detection Based On the Plasma Free Amino Acid Profile Identification of a Three-Biomarker Panel in Urine for Early Detection of Pancreatic Adenocarcinoma Early Detection of Pancreatic Cancer-a Defined Future Using Lessons From Other Cancers: A White Paper.Identification of IGFBP2 and IGFBP3 As Compensatory Biomarkers for CA19-9 in Early-Stage Pancreatic Cancer Using a Combination of Antibody-Based and LC-MS/MS-Based Proteomics The Role of CA19-9 in Predicting Tumour Resectability in Carcinoma Head of Pancreas Value of carbohydrate antigen 19-9 in predicting response and therapy control in patients with metastatic pancreatic cancer undergoing first-line therapy Prognostic Scoring Index for Patients with Metastatic Pancreatic Adenocarcinoma.Application of cancer-associated glycoforms and glycan-binding probes to an in vitro diagnostic multivariate index assay for precise diagnoses of cancer Biomarkers for pancreatic cancer: promising new markers and options beyond CA 19-9.Change in carbohydrate antigen 19-9 level as a prognostic marker of overall survival in locally advanced pancreatic cancer treated with concurrent chemoradiotherapy.An update on cancer risk and surveillance in primary sclerosing cholangitis.Early changes in plasma DNA levels of mutant KRAS as a sensitive marker of response to chemotherapy in pancreatic cancer.Distribution of circulating tumor DNA in lung cancer: analysis of the primary lung and bone marrow along with the pulmonary venous and peripheral blood.Cell-free DNA promoter hypermethylation in plasma as a diagnostic marker for pancreatic adenocarcinoma.Different clinical presentations of metachronous pulmonary metastases after resection of pancreatic ductal adenocarcinoma: Retrospective study and review of the literature.Raised CA19.9 and hepatic space occupying lesion after teriparatide therapy in a case of polyostotic fibrous dysplasia.Use of autoantibodies against tumor-associated antigens as serum biomarkers for primary screening of cervical cancer.Detection of K-ras gene mutations in feces by magnetic nanoprobe in patients with pancreatic cancer: A preliminary study.Detection of survivin, carcinoembryonic antigen and ErbB2 level in oral squamous cell carcinoma patients.CA19-9-related tumor kinetics after first-line chemotherapy of patients with advanced pancreatic cancer: a monoinstitutional experience.Promoter hypermethylation in plasma-derived cell-free DNA as a prognostic marker for pancreatic adenocarcinoma staging.Nomogram for predicting survival in patients with pancreatic cancer.Prognostic Value of Preoperative Serum Carcinoembryonic Antigen and Carbohydrate Antigen 19-9 After Resection of Ampullary Cancer.Clinical implication of serum carcinoembryonic antigen and carbohydrate antigen 19-9 for the prediction of malignancy in intraductal papillary mucinous neoplasm of pancreas.Combination of tumour markers CEA and CA19-9 improves the prognostic prediction in patients with pancreatic cancer.The outcome of cryoablation in treating advanced pancreatic cancer: a comparison with palliative bypass surgery alone.Dysbindin as a novel biomarker for pancreatic ductal adenocarcinoma identified by proteomic profiling.Multiplexed panel of precisely quantified salivary proteins for biomarker assessment.Biomarker-Based Therapy in Pancreatic Ductal Adenocarcinoma: An Emerging Reality?Programmed cell death 6 interacting protein (PDCD6IP) and Rabenosyn-5 (ZFYVE20) are potential urinary biomarkers for upper gastrointestinal cancer.Immunosensor for Pancreatic Cancer Based on Electrospun Nanofibers Coated with Carbon Nanotubes or Gold Nanoparticles.Droplet digital PCR quantification of miR-1290 as a circulating biomarker for pancreatic cancer

P2860

Q21132301-9653DF3F-01E3-4C19-BE00-9F704AB7C618 Q26746010-F41331B5-5ED6-4350-8DD0-C1D40DF8E277 Q29615778-D62DD437-99D5-4C73-ABE2-380AB07E8911 Q30393523-2F7C8A71-2616-4BF2-AD07-DF331C996DAD Q34405197-B8DBA1A8-03D4-4397-8E5B-6FC077ECCACF Q35680475-210C3240-E6C6-46A2-8849-A0C1494F3F94 Q35964357-D1FDB519-6E31-4A37-91C6-41EFD4C8E09E Q36102795-ADA67C5B-1E4C-4F17-AE90-01197487BB43 Q36118351-21A9B89F-B0C8-4CE8-80E2-7F050F794227 Q36831137-8B105E53-991B-4968-9155-8C1A10CCB9C8 Q36927697-0E38F0C8-E598-4589-A28C-7216DE9FC4A9 Q37367504-A1D151DD-C1AD-4052-88B1-A22444C8BA9B Q37565619-881C1451-E0C0-4F6C-AA83-B859BA864942 Q38129331-027C8388-748D-42C4-AE2C-99B7AEC008EB Q38801235-A9108B3E-E1BC-4177-BF76-B3BA97B9D50C Q39060326-3EFF2C73-B543-4D6E-9C84-D705B745B7A3 Q40495250-9428CDFC-EDFA-435B-B2BC-EF5F191CC7EC Q41708857-31EF11B4-982C-4BD8-B84E-D9C3F77FCCA4 Q41766645-0903A39C-A296-47AF-B6D8-87B8D72F487C Q42695251-DE5D88AF-5478-4BA2-9034-D54C02F27788 Q42966009-3CB51FCE-A984-4E17-9321-B4EF7D687D70 Q47097183-E4BB46BA-1226-47BE-AD34-5DA1A21B83A2 Q47100731-A3A589BB-63C5-4019-A924-BF01003B5C15 Q47679320-85408A88-9089-4B39-A552-35301FDB6E0D Q48113448-0F21B625-5825-4903-8B6F-A0A51D66DFBD Q48149907-539FBCBC-CCEC-4410-BBEE-C78089B685A3 Q49217510-24BEEA49-A310-4BC7-8095-9E097490D7AF Q50217905-652FD0A6-6CBA-4B69-854F-E254FF2C1BF7 Q50536915-EDA6C4CE-B5C1-43BC-ABDA-EBE8008C3746 Q50579768-60F904AD-D7FA-4304-9580-CEB9D12DA935 Q50665689-8C7B1C46-0BFA-42D1-B586-92FB048693FC Q51298601-53AAE850-B9D7-44ED-9737-711301F4F692 Q51564069-FE2129FA-8268-42C8-B3C6-D1AE5FA5942C Q52739894-00026C9F-A4D5-45BA-909F-21DD0A66B1B4 Q52970611-47AE2574-B0B1-4C36-A6EF-6485450E7051 Q55686939-E3F51BF9-E813-403C-91E4-2511AB0E0FFB Q58608805-F52822F6-2044-4471-9762-1030A3B462DB

P2860

Serum CA 19-9 as a Biomarker for Pancreatic Cancer-A Comprehensive Review.

http://www.wikidata.org/entity/Q38018315

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Serum CA 19-9 as a Biomarker for Pancreatic Cancer-A Comprehensive Review.

@en

type

label

Serum CA 19-9 as a Biomarker for Pancreatic Cancer-A Comprehensive Review.

@en

prefLabel

Serum CA 19-9 as a Biomarker for Pancreatic Cancer-A Comprehensive Review.

@en

P1433

Q38018315-A1C52073-7928-4DFD-9741-69FFD411DB8D

P1476

Q38018315-5D65359B-5450-47BC-9F2B-96DD96985040

P2093

Q38018315-9A417169-D5DF-4141-B02E-9DAD1A2B789A

Q38018315-9D0AD8D9-0FA8-4CEE-98E7-0C062798AD9E

P2860

Q38018315-0AAF46F8-DECC-49B4-BDCA-8511F93AD4B8

Q38018315-0C36B92E-A442-4072-BA03-19C30B9BB296

Q38018315-0ECC8271-D161-419D-93E7-899C78E5635E

Q38018315-0FC6A334-1E9D-445B-B3AE-501DE7D1D470

Q38018315-15C59A93-78AA-4C50-9E94-20B054542217

Q38018315-181EB807-A1AB-4AF4-A528-827D9F54A4B4

Q38018315-229C8B9C-D64A-4436-9EE4-77AB0AF3B489

Q38018315-2E16EE36-8891-4CF1-B628-438EA7E2A28C

Q38018315-3070562C-529C-4400-B0A4-B7D852E2553C

Q38018315-30C1A867-AFF4-4B8D-97E9-128D4F464290

P2888

Q38018315-FE1722C6-F4CF-431F-B51F-2A7421AA4F36

P304

Q38018315-59F5EC7F-A98C-4BCF-A155-259019A3D286

P31

Q38018315-4BE5A84C-5C30-4F9A-9F20-887D1F567557

P356

Q38018315-CCA8CFD8-8355-46A8-86DA-078D05F32E25

P433

Q38018315-0077082D-76DD-4B5A-9EF1-40EDE924D664

P478

Q38018315-AF676F94-7B80-4420-BBF1-A5B8DCCD7AD5

P577

Q38018315-6F15E349-254B-4938-83EF-12018501B3D5

P5875

Q38018315-BB0AEF40-C388-4BD9-8951-E34A0F5AA9C7

P6179

Q38018315-E9216AF7-8AE9-42A2-BBBE-BE028B904407

P698

Q38018315-C0CEB06D-8C33-456E-9D3C-11ACBCBD59AD

P921

Q38018315-86B58E34-E5B9-486C-8240-6CE129F3D2AB

P932

Q38018315-25722FE0-EF04-4E1F-82B4-69EC665BB49D

P356

S13193-011-0042-1

P1433

Indian Journal of Surgical Oncology

P1476

Serum CA 19-9 as a Biomarker for Pancreatic Cancer-A Comprehensive Review.

@en

P2093

Ronald S Chamberlain

http://www.w3.org/2001/XMLSchema#string

Umashankar K Ballehaninna

http://www.w3.org/2001/XMLSchema#string

P2860

Preoperative/neoadjuvant therapy in pancreatic cancer: a systematic review and meta-analysis of response and resection percentages

Systematic review of carbohydrate antigen (CA 19-9) as a biochemical marker in the diagnosis of pancreatic cancer

Prognostic factors in patients with locally advanced pancreatic carcinoma receiving chemoradiotherapy.

A compendium of potential biomarkers of pancreatic cancer.

Risk factors for pancreatic adenocarcinoma and prospects for screening.

Serum CA 19-9 as a marker of resectability and survival in patients with potentially resectable pancreatic cancer treated with neoadjuvant chemoradiation

Comparison of endoscopic ultrasonography and multidetector computed tomography for detecting and staging pancreatic cancer.

Perioperative CA19-9 levels can predict stage and survival in patients with resectable pancreatic adenocarcinoma.

Can preoperative CA19-9 and CEA levels predict the resectability of patients with pancreatic adenocarcinoma?

Prognostic impact of perioperative serum CA 19-9 levels in patients with resectable pancreatic cancer.

P2888

s13193-011-0042-1

P304

88-100

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S13193-011-0042-1

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

2

http://www.w3.org/2001/XMLSchema#string

P577

2011-02-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

225301959

http://www.w3.org/2001/XMLSchema#string

P6179

1042064486

http://www.w3.org/2001/XMLSchema#string

P698

22693400

http://www.w3.org/2001/XMLSchema#string

P921

P932

3244191

http://www.w3.org/2001/XMLSchema#string